Pfizer Drug Helped Cancer Patients Regain Weight, Study Shows
Pfizer Inc.’s experimental drug for cancer weight loss was shown to help patients regain weight in a mid-stage study, offering fresh promise for treating the dangerous muscle-wasting condition.
Semaglutide: Weight Loss Drug May Reduce Risk of Death
Adults with cardiovascular disease and excess weight took either semaglutide or a placebo and were monitored as part of a trial funded by semaglutide manufacturer Novo Nordisk. After an average of three years,
Pfizer drug shows promise in cancer-related condition that causes weight loss and weakness
Pfizer reported at #ESMO that an experimental antibody helped cancer patients with a condition known as cachexia.
Pfizer: Potential cachexia cancer drug shows life-saving promise
A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical tests, drug-maker Pfizer announced Saturday.
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
The results could pave the way for Pfizer's drug ponsegromab to become the first-ever approved treatment specifically for cancer cachexia.
Pfizer therapy succeeds in mid-stage trial for cancer-related weight loss
Pfizer's (PFE) experimental therapy for cancer related weight loss, ponsegromab, meets the primary endpoint in Phase 2 trial. Read more here.
KVIA27d
A study linking popular weight loss drug to suicide risk again raises long-standing safety questions
For some people, losing the pleasure and reward of eating — and perhaps other things — creates a dramatic shift in mood and may increase the risk of self-harm. In 2008, the weight loss drug ...
Knowridge11d
Research shows diabetes drug could reduce dementia risk. Here’s how diabetes and dementia may be linked
A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...
Study: Weight-loss drugs may reduce the risk of acute pancreatitis recurrence
Up to now, doctors have been cautious about prescribing semaglutide to patients with a history of pancreatitis, because they ...
New Research Suggests GLP-1 Drugs Like Ozempic May Reduce Cancer Risk
If you’ve found yourself unexpectedly humming the tune “Magic” lately, you’re not alone. Thanks to the catchy commercial for ...
AOL23d
Popular weight loss drug found to reduce risk of heart complications, study shows
Taking a weight loss drug may also help reduce the risk of heart attack, stroke and cardiac death, data shows. Wegovy, a drug approved by the U.S. Food and Drug Administration to treat ...
Everyday Health3d
Wegovy May Reduce the Risk of Death From COVID-19, Study Suggests
The findings open up new avenues for exploring how this class of weight loss drugs may benefit people, says Dr. Scirica. Wegovy Is Already Known to Reduce Risk of Death From Heart Disease ...
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linked
A recent study found people taking a particular type of diabetes drug had a lower risk of developing dementia.
mskcc.org25d
Cancer Benefits and Risks From Ozempic, Wegovy, and Other Weight Loss Drugs
Many of his patients ask him about the new weight loss ... the medications may be an important new tool for treating the epidemic of obesity and related conditions that can cause serious health ...
ABC News23d
Popular weight loss drug found to reduce risk of heart complications, study shows
Wegovy is part of a class of drugs called GLP-1 Receptor Agonists. Taking a weight loss drug may also help reduce the risk of heart attack, stroke and cardiac death, data shows. Wegovy, a ...